MMP7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.470800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.539600E-01
Normal-vs-Stage2
3.633000E-01
Normal-vs-Stage3
1.936580E-01
Normal-vs-Stage4
2.035400E-01
Stage1-vs-Stage2
3.980300E-03
Stage1-vs-Stage3
4.187600E-01
Stage1-vs-Stage4
5.307400E-01
Stage2-vs-Stage3
5.771600E-01
Stage2-vs-Stage4
6.084000E-01
Stage3-vs-Stage4
9.732800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.440200E-01
Normal-vs-AfricanAmerican
3.795000E-01
Normal-vs-Asian
4.188000E-01
Caucasian-vs-AfricanAmerican
7.762800E-01
Caucasian-vs-Asian
3.469200E-01
AfricanAmerican-vs-Asian
6.939800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.367200E-01
Normal-vs-Female
3.619400E-01
Male-vs-Female
4.532200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.453200E-01
Normal-vs-Age(41-60Yrs)
3.928800E-01
Normal-vs-Age(61-80Yrs)
3.302400E-01
Normal-vs-Age(81-100Yrs)
3.308000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.212200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.454800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.349600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.605600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.431400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.789000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.762000E-01
Normal-vs-Daily Drinker
3.584200E-01
Normal-vs-Weekly Drinker
2.914800E-01
Normal-vs-Occasional Drinker
3.026800E-01
Normal-vs-Social Drinker
2.899200E-01
Non Drinker-vs-Daily Drinker
7.526800E-01
Non Drinker-vs-Weekly Drinker
1.285550E-01
Non Drinker-vs-Occasional Drinker
1.584820E-01
Non Drinker-vs-Social Drinker
6.543000E-01
Daily Drinker-vs-Weekly Drinker
1.925220E-01
Daily Drinker-vs-Occasional Drinker
2.544600E-01
Daily Drinker-vs-Social Drinker
5.541000E-01
Weekly Drinker-vs-Occasional Drinker
7.670600E-01
Weekly Drinker-vs-Social Drinker
2.255200E-01
Occasional Drinker-vs-Social Drinker
2.702400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.263200E-01
Normal-vs-Grade 2
7.321600E-02
Normal-vs-Grade 3
1.757000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.340400E-03
Grade 1-vs-Grade 3
1.205800E-02
Grade 1-vs-Grade 4
2.263200E-01
Grade 2-vs-Grade 3
7.329400E-01
Grade 2-vs-Grade 4
7.321600E-02
Grade 3-vs-Grade 4
1.757000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.452000E-01
Normal-vs-NonDiabetic
3.599200E-01
Diabetic-vs-NonDiabetic
7.075600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.716800E-01
Normal-vs-NoPancreatitis
3.433400E-01
Pancreatitis-vs-NoPancreatitis
4.853800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.144400E-01
Normal-vs-N1
3.686400E-01
N0-vs-N1
1.114620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.637000E-01
Normal-vs-TP53-NonMutant
2.953600E-01
TP53-Mutant-vs-TP53-NonMutant
1.382170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
